Ipsen
Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.
About
Ipsen is a global biopharmaceutical company focused on improving people's lives and health outcomes by accelerating its momentum and boosting its pipeline to bring innovative medicines to patients. The company concentrates its efforts on oncology, rare disease, and neuroscience, areas with high unmet medical needs. Ipsen serves patients and society by developing new therapies and fostering valuable collaborations. Teams look it up for Biotech, MedTech, HealthTech.
Frequently asked
What does Ipsen do?
Ipsen is a Biotech company that offers Software | hardware | services | marketplace | platform. Teams look it up for MedTech, HealthTech, Genomics. It is based in Paris, France and was founded in 1929. Public records show about 6,664 people. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
Where is Ipsen headquartered?
Ipsen is headquartered in Paris, France.
When was Ipsen founded?
Ipsen was founded in 1929.
What industry does Ipsen operate in?
Ipsen operates in Biotech, MedTech, HealthTech, Genomics, Drug Discovery.
How many employees does Ipsen have?
Ipsen has approximately 6,664 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.